These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1697132)

  • 61. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1990 Feb; 263(6):793. PubMed ID: 1688632
    [No Abstract]   [Full Text] [Related]  

  • 62. Phase I study of fludarabine (2-fluoro-ara-AMP).
    Kavanagh JJ; Krakoff IH; Bodey GP
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1009-11. PubMed ID: 2415365
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Responses of patients to arabinosyladenine-5'-phosphate correlated with an in vitro test.
    Lepage GA; Khaliq A
    Adv Enzyme Regul; 1978; 17():437-54. PubMed ID: 93404
    [No Abstract]   [Full Text] [Related]  

  • 64. Fludarabine therapy in macroglobulinemic lymphoma.
    Kantarjian HM; Alexanian R; Koller CA; Kurzrock R; Keating MJ
    Blood; 1990 May; 75(10):1928-31. PubMed ID: 1692487
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.
    Lok AS; Wilson LA; Thomas HC
    J Antimicrob Chemother; 1984 Jul; 14(1):93-9. PubMed ID: 6207158
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Delayed clearance of HBsAG after transplantation for fulminant delta-hepatitis.
    Vogel W; Dietze O; Judmaier G; Then P; Schmid T; Margreiter R
    Lancet; 1988 Jan 2-9; 1(8575-6):52. PubMed ID: 2891909
    [No Abstract]   [Full Text] [Related]  

  • 67. Aranucleosides and aranucleotides in viral chemotherapy.
    North TW; Cohen SS
    Pharmacol Ther; 1979; 4(1):81-108. PubMed ID: 88745
    [No Abstract]   [Full Text] [Related]  

  • 68. The clinical course of acute type A hepatitis in chronic HBsAg carriers--a report of 3 cases.
    Viola LA; Barrison IG; Coleman JC; Murray-Lyon IM
    Postgrad Med J; 1982 Feb; 58(676):80-1. PubMed ID: 7100029
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Galactosylated poly(L-lysine) as a hepatotropic carrier of 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
    Fiume L; Bassi B; Busi C; Mattioli A; Spinosa G; Faulstich H
    FEBS Lett; 1986 Jul; 203(2):203-6. PubMed ID: 2426140
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial.
    Zarski JP; Barange K; Souvignet C; Bertini M; Marcellin P; Tran A; Deugnier Y; Couzigou P; Plages A; Ambroise-Thomas P
    J Hepatol; 2001 Mar; 34(3):486-8. PubMed ID: 11322216
    [No Abstract]   [Full Text] [Related]  

  • 71. Hepatitis update.
    Dong B; Barton E; Mancini B
    Nurse Pract; 1988 Apr; 13(4):69. PubMed ID: 3362445
    [No Abstract]   [Full Text] [Related]  

  • 72. [Studies on the toxicity of acyclovir and adenine arabinoside 5'-monophosphate to the rabbit cornea (author's transl)].
    Shiota H; Ogawa T; Inoue S; Yamane S
    Nippon Ganka Gakkai Zasshi; 1980 Sep; 84(9):1190-7. PubMed ID: 6164277
    [No Abstract]   [Full Text] [Related]  

  • 73. Delta hepatitis in resolved hepatitis B.
    Ponzetto A; Ciancio A; Figura N
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1528. PubMed ID: 30395014
    [No Abstract]   [Full Text] [Related]  

  • 74. High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasma.
    Smith GA; Giacomini KM; Smith CT; Gregory PB; Robinson WS; Merigan TC; Blaschke TF
    J Chromatogr; 1984 May; 307(2):410-5. PubMed ID: 6203924
    [No Abstract]   [Full Text] [Related]  

  • 75. Conformation of N(9)-(beta-D-arabinofuranosyl) adenine 5'-monophosphate (ara-AMP) in anhydrous dimethylsulphoxide monitored by 13C NMR.
    Mikhailopulo IA; Cramer F
    FEBS Lett; 1982 Jul; 144(1):109-11. PubMed ID: 6179800
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparative animal toxicology of vidarabine and its 5'-monophosphate.
    Kurtz SM; Fitzgerald JE; Schardein JL
    Ann N Y Acad Sci; 1977 Mar; 284():6-8. PubMed ID: 81644
    [No Abstract]   [Full Text] [Related]  

  • 77. A labeled 9-beta-D-arabinofuranosyladenine 5'-monophosphate having increased metabolic stability.
    Baker DC; Haskell TH
    Ann N Y Acad Sci; 1977 Mar; 284():30-3. PubMed ID: 81638
    [No Abstract]   [Full Text] [Related]  

  • 78. Ribavirin therapy in chronic delta hepatitis.
    Buti M; Esteban R; Jardi R; Rodriguez F; Guardia J
    J Hepatol; 1993 Sep; 19(2):318. PubMed ID: 8301069
    [No Abstract]   [Full Text] [Related]  

  • 79. Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
    Garcia G; Smedile A; Bergmann KF; Gerin JL; Gregory PB; Merigan TC; Robinson WS
    West J Med; 1990 Jul; 153(1):80-2. PubMed ID: 1697132
    [No Abstract]   [Full Text] [Related]  

  • 80. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
    Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
    JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.